Tiburio

Tiburio is a pharmaceutical company that researches and develops novel therapeutics for the treatment of neuroendocrine tumors and endocrine diseases. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

Tiburio

Tiburio is a pharmaceutical company that researches and develops novel therapeutics for the treatment of neuroendocrine tumors and endocrine diseases. Read more

Abraham N Ceesay's photo - President & CEO of Tiburio

President & CEO

Abraham N Ceesay

CEO Approval Rating

89/100

Founded:

2019

Status:

PrivateIndependent Company

TIBURIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Alector is perceived as one of Tiburio's biggest rivals. Alector's headquarters is in South San Francisco, California, and was founded in 2013. Alector operates in the Biotechnology industry. Alector generates 6,805% of Tiburio's revenue.

ProMIS has been one of Tiburio's top competitors. ProMIS is a Public company that was founded in 2004 in Toronto, Ontario. ProMIS is in the Pharmaceuticals field. Compared to Tiburio, ProMIS has 14 fewer employees.

Yumanity Therapeutics is Tiburio's #3 rival. Yumanity Therapeutics was founded in Boston, Massachusetts} in 2014. Yumanity Therapeutics operates in the Biotechnology industry. Compared to Tiburio, Yumanity Therapeutics generates $5.7M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 15 a good estimate for Tiburio's Employee count?

Tiburio Acquisitions

No recent acquisitions found related to Tiburio

Tiburio Funding History

$5M$36M

Since Tiburio was founded in 2019, it has participated in 2 rounds of funding. In total Tiburio has raised $36.0M. Tiburio's last funding round was on Jan 2019 for a total of $31.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Jan 2019
$31M
Equity
Dec 2018
$5M

New Enterprise Associates

Since Tiburio was founded in 2019, it has participated in 2 rounds of funding. In total Tiburio has raised $36.0M. Tiburio's last funding round was on Jan 2019 for a total of $31.0M

Tiburio Investments

No recent investments found related to Tiburio

Tiburio News

Social Media

Tiburio Headquarters

700 Technology Square 2nd Floor

Cambridge, Florida02139

617-231-6050

Driving Directions »

Trending Companies

Tiburio Summary

ABOUT

Overview

Tiburio is a pharmaceutical company that researches and develops novel therapeutics for the treatment of neuroendocrine tumors and endocrine diseases. Tiburio was founded in 2019. Tiburio's headquarters is located in Cambridge, Florida, USA 02139. It ...

CEO

Tiburio's President & CEO, Abraham N Ceesay, currently has an approval rating of 89%. Tiburio's primary competitors are Alector, ProMIS & Yumanity Therapeutics.

Website

tiburio.com

Frequently Asked Questions about Tiburio

  1. When was Tiburio founded?

    Tiburio was founded in 2019
  2. Who is Tiburio's CEO?

    Tiburio's CEO is Abraham N Ceesay
  3. How much revenue does Tiburio generate?

    Tiburio generates $ < 1M in revenue
  4. How much funding does Tiburio have?

    Tiburio has historically raised $36M in funding
  1. Where is Tiburio's headquarters?

    Tiburio's headquarters is in Cambridge Florida, USA
  2. How many employees does Tiburio have?

    Tiburio has 15 employees
  3. What sector does Tiburio operate in?

    Tiburio is in Biotechnology
  4. Who are Tiburio's competitors?

    Tiburio's top competitors are Alector, ProMIS, Yumanity Therapeutics